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Abstract The intestinal microbiota of the horse, an animal of huge economic and 21 
social importance worldwide, is essential to the health of the animal. Understanding 22 
the intestinal ecosystem and its dynamic interaction with diet and dietary supplements 23 
currently requires the use of experimental animals with consequent welfare and 24 
financial constraints. Here, we describe the development and assessment, using 25 
multiple analytical platforms, of a three vessel, continuous flow, in vitro model of the 26 
equine hindgut. After inoculation of the model with fresh horse feces, the bacterial 27 
communities established in each vessel had similar taxonomic distribution to that of 28 
the source animal. Short chain and branched chain fatty acid (SCFA/BCFA) production 29 
within the model at steady-state was consistent with expected bacterial function 30 
although higher concentrations of some SCFA/BCFAs, were apparent relative to that 31 
of ex vivo gut content. We demonstrate inter-model repeatability and the ability of the 32 
model to capture some aspects of individual variation in bacterial community profiles. 33 
This proof-of-concept study, including recognition of model limitations, supports its 34 
future development as a tool for investigating the impact of disease, nutrition, dietary 35 
supplementation and medication on the equine intestinal microbiota. 36 
Importance The equine gut model that we have developed and described has the 37 
potential to facilitate the exploration of how the equine gut microbiota is affected by 38 
diet, disease and medication. It is a convenient, cost-effective and welfare-friendly 39 
alternative to in vivo research models. 40 
 41 
INTRODUCTION 42 
Commensal bacteria that reside within the large intestine of the equine gastrointestinal 43 
tract are vital for the horse to be able to utilise a forage-based diet. Some of these 44 
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bacteria produce short chain fatty acids (SCFAs), which are absorbed through the gut 45 
wall and contribute to the energy requirements of the horse. Sequencing of bacterial 46 
16S rRNA genes from gastrointestinal content or feces has been used to profile the 47 
gut microbiota of healthy horses (1–5) and to assess the impact of diseases such as 48 
colitis and grass sickness on equine fecal bacterial communities (6,7). In common with 49 
the majority of human microbiota studies, most disease-related studies have 50 
characterized the equine fecal microbiota due to ease of access to samples. Equine 51 
feces have been shown to be broadly representative of bacterial communities within 52 
distal parts of the large colon (1) and to more orad parts of the intestinal tract. 53 
To accurately analyze bacterial communities within the gastrointestinal tract of 54 
the horse, direct sampling of each region of interest would be ideal. While this can be 55 
done post-mortem or with fistulated horses, both techniques have limited application 56 
due to financial, ethical and welfare implications. Therefore, a fermentation model 57 
representing the microbiota of the equine large intestine in vitro would facilitate this 58 
important area of equine health research, enhancing our ability to explore the impact 59 
of diet, pathogens, novel foodstuffs, dietary supplements and drugs on the equine gut 60 
microbiota. 61 
 Models of the human gut have been a valuable and widely used research tool 62 
(8). Studies have shown how an intervention with galactooligosaccharide (GOS) has 63 
similar effects on the microbial community in vitro when compared to in a human study 64 
population (9). In vitro and in vivo approaches were taken to study the effect of the 65 
prebiotic GOS on the gut microbiota of children with autism (10,11). Both approaches 66 
demonstrated an increase in butyrate production (in the gut model and human feces 67 
respectively) suggesting that the model is metabolically valid. Gut models have 68 
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provided preliminary insights on the effects of dietary supplement or drug on the 69 
human gut microbiota before commencing costly human trials. 70 
In vitro fermentation models developed to represent bacterial activity in the 71 
equine gastrointestinal tract have been reported previously (12–20). However, the 72 
majority of these models have used a simple medium or equine feed to maintain fecal 73 
bacterial populations and do not replicate the continuous flow of ingesta through the 74 
gastrointestinal tract (12,13,16–22). These models often use gas production as a 75 
marker of bacterial function and measure the kinetic properties of the bacterial 76 
populations cultured (13,17–21). Sequencing of bacterial DNA from fermentation 77 
samples allows for a more comprehensive overview of the bacterial communities 78 
present, however this approach has so far only been reported in one equine 79 
fermentation study (14). 80 
In this study, we report on the development and performance of a three-stage 81 
fermentation model designed to simulate bacterial communities in the equine large 82 
intestine. Two experiments were designed: i) a concordance study of three individual 83 
gut models, each inoculated with feces from a different horse (post-mortem), to 84 
evaluate the extent to which the gut bacterial profiles of individual horses are 85 
replicated, and  ii) a repeatability study of two gut models inoculated with feces from 86 
the same horse (pre-mortem). To analyse samples taken from the vessels of the gut 87 
model we used fluorescence in situ hybridization (FISH) analysis to assess total 88 
bacterial numbers and 16S rRNA bacterial gene sequencing to characterize the 89 
microbial community profile in vitro, compared to the samples taken ex vivo. Proton 90 
nuclear magnetic resonance (1H NMR) spectroscopy and gas chromatography were 91 
used to measure a broad range of metabolites to evaluate the functional activity of the 92 
model microbiota. Specifically we report on i) model concordance with in vivo gut 93 
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bacterial populations, ii) repeatability of the model, and iii) the ability of the model to 94 
capture individual variation in bacterial community profile. 95 
 96 
RESULTS 97 
Gut model medium was adapted to reflect a normal equine diet 98 
The acid detergent fibre (ADF) and starch content of gastrointestinal content samples 99 
were analyzed to inform the compositional changes made to the gut model media. We 100 
aimed to replicate the diet of the average UK leisure horse in the media used to feed 101 
the model. A large percentage of the gastrointestinal content of the equine ileum, large 102 
colon and feces was acid detergent fibre (ADF, Figure S1). Feces had the highest 103 
percentage of ADF (42.9 % ± 3.9 %) and the lowest percentage of starch (0.56 % ± 104 
0.49 %), whereas the ileal content had the lowest percentage of ADF (25.9 % ± 10.8 105 
%) and the highest percentage of starch (3.8 % ± 3.3 %). The analysis of ADF and 106 
starch from ileum content informed the cellulose and starch content of the gut model 107 
media used to feed the model. 108 
 109 
The equine in vitro gut model can support a metabolically functioning bacterial 110 
population 111 
The concentrations of five short chain and branched chain fatty acids (SCFA/BCFA) 112 
produced in each vessel of the in vitro gut models were measured during the 113 
concordance study to assess the metabolic output of bacterial fermentation. Figure 1 114 
shows the concentration of acetate, propionate, butyrate, isobutyrate and valerate in 115 
the three vessels, as a mean of the three separate gut models. Concentrations of 116 
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acetate and propionate rose quickly in all three vessels after initial inoculation (Figure 117 
1A and B). Concentrations of butyrate, isobutyrate and valerate only increased 118 
marginally between T-1 and T0, but then increased sharply after the flow of media was 119 
started at T0 (Figure 1C, D and E). The mean concentration for all SCFA/BCFA 120 
measured was observed to stabilise in all three vessels by T5 as there was no 121 
significant change in concentration between T3 and T5 (p > 0.05). 122 
 The metabolic profiles of the three gut models in the concordance study were 123 
compared to that of the gastrointestinal content of the donor horses. Figure 2 shows 124 
the PCA model (R2 = 0.64) built with metabolic data from gastrointestinal contents, 125 
feces from the rectum and all samples taken from the three gut models. The PCA 126 
scores plot shows that the largest source of variation within the dataset (PC1, 127 
representing 50 % of the total variation the dataset) was explained by samples taken 128 
from the model after T1 having higher concentrations of acetate (Figure 2A and B). 129 
Within the second principle component (PC2) of this PCA model samples of 130 
gastrointestinal content clustered away from samples from the gut models 131 
(representing 15 % of the total variance, Figure 2A). This was due to the content of 132 
the large colon having higher concentration of acetate compared to the gut model 133 
(Figure 2C). 134 
 A PCA model was constructed with the metabolic profiles of the gastrointestinal 135 
content and samples taken from the three concordance study models at T5 (R2 = 136 
0.64). There was separation of points representing samples from the two groups in 137 
PC1 (explaining 48 % of the variance in the dataset) in the PCA scores plot (Figure 138 
S2A) indicating metabolic differences between samples of gastrointestinal content and 139 
gut model. When these differences were explored further, samples of gastrointestinal 140 
content had higher concentrations of acetate whereas the samples from the gut model 141 
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at T5 had higher levels of valerate and propionate (Figure S2B). An OPLS-DA model 142 
was also built with the metabolic spectra from these two groups of samples (Q2Y = 143 
0.82). This supervised model highlighted differences in levels of acetate, propionate 144 
and valerate (also evident in the PCA model) alongside higher levels of diethylene 145 
glycol (DEG), ethanol, trimethylamine (TMA) and iso-valerate in samples from the gut 146 
models (Figure S2C). 147 
 148 
The equine gut model can replicate part of the equine large intestinal microbiota 149 
An estimate of total bacteria was created using FISH analysis to assess bacterial 150 
concentration within the gut model after fecal inoculation. Mean total bacteria for the 151 
three gut models of the concordance  study were lower in the vessels of the gut model 152 
at T-1 (2.68 x 108, 2.86 x 108, 2.21 x 108 bacteria per ml) compared to gastrointestinal 153 
content (3.93 x 108, 3.40 x 108, 3.32 x 108 bacteria per ml). At T0 bacterial counts had 154 
risen in all three vessels (2.81 x 108, 4.02 x 108, 3.69 x 108 bacteria per ml). By T5 155 
(steady state) bacterial proliferation had plateaued, with vessel one having the highest 156 
counts (5.51 x 108 bacteria per ml) and vessel three the lowest (3.74 x 108 bacteria 157 
per ml). Bacterial alpha diversity (measured as observed OTUs) within the gut models 158 
at T0 and T5 was significantly lower than the bacterial diversity of gastrointestinal 159 
content and the models at T-1 (p < 0.05, Figure S3A) 160 
 Unsurprisingly bacterial community profile at phylum level of the model at T-1 161 
(immediately after inoculation) was similar of that of gastrointestifnal content of the 162 
horses that provided feces for inoculation (Figure 3). However, the abundance of 163 
Verrucomicrobia was greater in the in vitro gut models immediately after inoculation 164 
(T-1) than in the gastrointestinal content (14 % vs 1 %, p < 0.05). After the gut models 165 
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were batch-cultured for 24 hours (T0) an increased abundance of Proteobacteria (from 166 
an average of 2 % to 27 %) and Firmicutes (from an average of 40 % to 64 %) was 167 
observed in all vessels (p < 0.05 from T-1 to T0 for both bacterial phyla). However, by 168 
T5 the relative abundance of Firmicutes and Bacteroidetes was comparable to that of 169 
the gastrointestinal content; and the relative abundance of Proteobacteria was much 170 
reduced relative to T0 (from an average of 37% to 8%, p < 0.05).  171 
 On average, samples taken directly from the cecum were composed of 40 % 172 
Bacteroidetes and 46 % Firmicutes (as a mean of the three horses sampled).  173 
Whereas, in the gut model these proportions of bacteria were 21 % and 59 % (as an 174 
average for vessel 1 of the three models of the concordance study), respectively. For 175 
right ventral colon the proportions were 40 % and 47 % for the gut contents and  15 % 176 
and 53 % in the gut model (vessel 2), respectively and for the left ventral colon the gut 177 
contents proportions were 37% and 50% and gut model proportions 25 % and 48 %, 178 
respectively (vessel 3).  179 
 Interestingly, the percentage of the bacterial community within the in vitro gut 180 
model that was identified as Bacteroidetes decreased further down the model (from 181 
vessel 1 to 3), similar to the changes observed in aboral regions of the large colon. 182 
There were higher levels of Bacteroidetes in vessel three of model one (M1V3), than 183 
in vessel three of the other two models (M2V3 and M3V3). There was a higher relative 184 
abundance of Synergistetes in the gut model at T5 (mean of all three vessels = 14 %) 185 
compared to the gastrointestinal content (< 1%). There were also slight differences in 186 
bacterial communities of the three models (M1, M2 and M3), inoculated with feces 187 
from different horses. M2 had a significantly higher percentage of reads identified as 188 
Firmicutes compared to M3 (p < 0.05) and M3 had a significantly higher percentage of 189 
Verrucomicrobia and Synergyistetes bacteria than the other two models (p < 0.05). 190 
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 The mean SCFA/BCFA concentration and bacterial phyla count for each vessel 191 
of the concordance study gut models were used to build regression models. A number 192 
of the models built showed a positive correlation between SCFA/BCFA and bacterial 193 
phyla with good model fit (R2 > 0.5). However only a few of these associations were 194 
significant (p < 0.05), these included: Fusobacteria and acetate (V1), Synegistetes and 195 
valerate (all vessels) and Synegistetes and isobutyrate (V1 and V3). For R2 and p 196 
values for regression analyses see Table S2. 197 
 Bacterial community profiles were also illustrated at class and order level 198 
(Figure S4). The bacterial class Clostridia (on average 47 % in gastrointestinal 199 
samples and 53 % in all vessels of the gut model at T5) and order Clostridiales (47 % 200 
and 53 %) were at the same percentage abundance as the Firmicutes phylum (48 % 201 
and 53 %) and the class Bacteroidia (37 % and 21 %) and order Bacteroidales (37 % 202 
and 21%) were at the same percentage abundance as Bacteroidetes phylum (39 % 203 
and 21 %) in all gastrointestinal and gut model samples. Differences associated with 204 
differing relative abundance of Clostridia/Clostridiales and Bacteroidia/Bacteroidales 205 
were observed between the gut models inoculated with different feces. 206 
 Venn diagrams were produced to visualise the number of distinct operational 207 
taxonomic units (OTUs, bacterial groups with different taxonomic classification) that 208 
were shared between the three vessels of the gut models (at T5) of the concordance 209 
study and their corresponding region of the equine large intestine (Figure 4). Vessel 3 210 
shared the highest number of OTUs, with 57 OTUs (59 % of the total OTUs identified 211 
in samples from vessel 3) being common between vessel 3 and content from the left 212 
ventral colon. Vessel 2 shared 53 OTUs (56 %) with the right ventral colon samples 213 
and vessel 1 shared 47 OTUs (57 %) with cecum samples.  214 
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 215 
The metabolic and microbial profile created by the equine gut model is 216 
repeatable. 217 
The concentration of the five SCFA/BCFA measured using gas chromatography 218 
significantly rose between T-1 and T1 in all of the vessels of the two gut models of the 219 
repeatability study, before plateauing (p < 0.05, Figure 5). As with the concordance 220 
study, the models from the reproducibility study were deemed to be stable by T5 (p > 221 
0.05 for all SCFA/BCFA between T3 and T5). The concentration of butyrate and 222 
valerate slightly decreased after steady state was reached (between T5 and T7), but 223 
this was not significant (p > 0.05). Furthermore, the concentration of the five 224 
SCFA/BCFA measured by gas chromatography was not significantly different in the 225 
two models of the repeatability study (p > 0.05 for all SCFA/BCFA at all turnovers). 226 
 The reproducibility of the metabolic signature of the two gut models was 227 
assessed by building a PCA model with the 1H NMR spectra gained from the two gut 228 
model of the repeatability study (R2 = 0.75, Figure S5). The largest source of variation 229 
within this dataset (PC1, representing 63 % of the total variance in the model) was the 230 
increase in concentration of propionate and acetate over the first four days of the 231 
model (T-1 to T1). Points representing samples from the two different models clustered 232 
together after T1, indicating that the two models were metabolically similar. 233 
 Total bacteria counts calculated by FISH were similar in the two gut models of 234 
the repeatability study (M4 and M5). M4 had slightly more bacteria in all three vessels 235 
at T5 compared to M5 (mean bacteria per ml for M4 was 4.02 x 108 and M5 was 3.88 236 
x 108), but this was not statistically significant (p > 0.05). There was a slight increase 237 
in total bacteria between T5 and T7 in all of the vessels of the two gut models of the 238 
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repeatability study (on average the total bacteria of all vessels increased by 3.74 x 239 
107), but this was not statistically significant (p > 0.05). 240 
 The bacterial alpha diversity (measured as observed OTUs) within the models 241 
at T0, T5 and T7 was significantly lower than the bacterial diversity of the fecal sample 242 
used as inoculum and the model at T-1 (p < 0.05, Figure S3B). However, bacterial 243 
diversity in the models did not significantly change between T5 and T7 (p > 0.05). 244 
Bacterial community profiles were constructed for the two gut models of the 245 
repeatability study to assess reproducibility of the equine gut model (Figure 6). There 246 
were no significant differences between the two models when the bacterial phyla 247 
identified in each of the three vessels at models at T5 were compared (p > 0.05). There 248 
were also no significant differences between the bacterial phyla profile of each vessel 249 
at T5 and T7 (p > 0.05). Bacterial community profiles at class and order level were 250 
similar between the two models of the repeatability study and stable between T5 and 251 
T7 (Figure S6). 252 
 253 
DISCUSSION  254 
We have presented a description of an in vitro model of the equine hindgut and have 255 
examined it against intestinal content samples taken from euthanized horses. This 256 
allowed for the assessment of the equine gut model’s ability to maintain bacterial 257 
communities representative of that found in vivo, the repeatability of the gut model 258 
setup and the model’s ability to capture individual variation that exists in the gut 259 
microbial communities of horses. Models, by definition, are not exact representations 260 
of reality. We acknowledge that a model of the equine microbiota will never be an 261 
exact replica of the real bacterial community within the equine large intestine. The 262 
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model will however replicate aspects of the microbial community to allow interrogation 263 
and experimental manipulation in a more convenient and less invasive way. Data 264 
presented in this paper demonstrate the strengths and limitations of this novel gut 265 
model system and its potential to extend our understanding of equine intestinal health. 266 
 The three equine gut models of the concordance study showed that the fecal 267 
bacteria introduced to the gut model were able to metabolize the gut model media and 268 
produce SCFA/BCFA. Immediately after inoculation with feces, the abundance of 269 
acetate and propionate within the model increased sharply. Butyrate, isobutyrate and 270 
valerate were not observed to notably increase over the first 24 hours. However, these 271 
three SCFA/BCFA rose sharply in all three vessels during the first three days of being 272 
fed with media. Differences in the timing of SCFA/BCFA appearance may reflect 273 
differential acclimatization of the fecal bacterial communities to the gut model 274 
environment; bacterial communities producing acetate and propionate adapting to the 275 
environment more rapidly than those producing butyrate, isobutyrate and valerate. By 276 
T5, production of all five SCFA/BCFA had stabilized and the models were deemed to 277 
have entered “steady state”. In human gut model studies this is the point at which a 278 
food supplement or drug intervention is added to be studied (10,23–26).  279 
Multivariate statistical models were used to identify metabolic differences 280 
between gastrointestinal content and the gut models. Ethanol, valerate, iso-valerate, 281 
propionate, DEG and TMA were at higher concentrations in the gut model at steady 282 
state compared to gastrointestinal content. Choline can be degraded by the gut 283 
microbiota to liberate ethanol and TMA. Ethanol can also be produced via the 284 
metabolism of keto acids and saturated fatty acids following the microbial breakdown 285 
of amino acids. Similarly, iso-valerate arises from the microbial degradation of leucine. 286 
These findings indicate that the functional capacity of the equine gut microbiota to 287 
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liberate amino acids from ingesta is preserved in the gut model system. The 288 
accumulation of theses metabolites is most likely due to the lack of absorption in the 289 
vessels of the gut model system. However, acetate was present in lower amounts in 290 
the equine gut model compared to gastrointestinal contents. Acetate is a product of 291 
bacterial carbohydrate fermentation and is usually absorbed by the gut wall so it can 292 
undergo further metabolism to generate ATP. Acetate concentrations in V1 of the 293 
concordance study models were found to be significantly positively correlated with the 294 
presence of known acetate producing bacterial phyla Fusobacteria (27,28). Lower 295 
levels of acetate in the gut model suggest that carbohydrate availability may be less 296 
in the gut model or that some of the carbohydrate-fermenting bacteria cannot be 297 
supported. Alternatively, the acetate produced could be washed through the gut model 298 
system into the waste by the constant flow of media. The high levels of acetate in 299 
gastrointestinal content emphasises the importance of acetate-generating bacteria to 300 
enable horses to liberate energy from their diet. 301 
 FISH analysis of samples of gastrointestinal content and the vessels of the 302 
concordance study gut models provided an estimate of the number of total bacteria in 303 
the two sample types. The mean concentration of bacteria in vessel one was higher 304 
than that seen in the cecum, but this was also the vessel in which total bacteria varied 305 
the most between the three gut models from the concordance study. The differences 306 
in total bacteria between the three vessels was similar to that seen in the three sample 307 
sites of the large intestine although they are more pronounced in the gut model. This 308 
may be due to the progressive nutrient depletion as media passes through the model 309 
system. 310 
 We chose to use 16S gene sequencing for taxonomic characterisation of the 311 
bacterial communities present in the model. The advantages of this method are 312 
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efficiency and breadth of coverage but we also recognise the disadvantage of limited 313 
resolution and specificity. A more balanced approach for future studies might include 314 
the use of quantitative PCR for targeted taxonomic (and functional) markers of interest. 315 
Future characterisation of this model system could also include evaluation of the 316 
virome and mycobiome. 317 
 Bacterial community profiles of the gastrointestinal content samples that we 318 
used were consistent with those reported previously (5) and dominated by 319 
Bacteroidetes and Firmicites. Immediately after inoculation all three vessels of the gut 320 
models had a similar composition to fecal samples. After the first 24 hours of 321 
fermentation between T-1 and T0, there is a shift in the bacterial populations, where 322 
Proteobacteria and Firmicutes become dominant. However, by T5 the percentage of 323 
Firmicutes and Bacteroidetes bacteria in the three vessels did not significantly differ 324 
from the equivalent regions of the large intestine and the initial Proteobacteria 325 
overgrowth was reduced.  326 
It is worth noting, however, that not all the populations present in gut content 327 
samples were restored in the model on reaching steady state. This situation will be 328 
largely dictated by the diet of the horse providing samples for inoculation of the model 329 
system, as compared to the nutrients available within the model media. Varying the 330 
carbon and nitrogen sources in the media could aid the growth of a more diverse range 331 
of organisms. Change in bacterial community dynamics have been observed in human 332 
gut models by varying media composition and model retention time (8). In equine and 333 
human gut model systems, the media flowing through the model means that different 334 
nutrient availability occurs in different regions, enabling different environmental 335 
conditions to be modelled, supporting growth of different microbial populations at 336 
different enteric sites. The bacterial community within the equine model system could 337 
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be treated with different foods, bacteria or antibiotics to determine the impact of dietary 338 
changes on the microbiota, this could therefore aid in determining whether certain 339 
changes may be of benefit or not to a horse. Indeed, the advantage of a model system 340 
is the diet is very well controlled, therefore, if a test substrate is added after steady 341 
state has been reached, subsequent changes will be known to be a result of the 342 
substrate. 343 
 The bacterial profile for vessel three of model one (M1V3) seen in Figure 3 had 344 
a higher percentage of Bacteroidetes than expected; the percentage of Bacteroidetes 345 
usually decreases from vessel two to vessel three (as can be seen in M2 and M3). 346 
This high level of Bacteroidetes is likely to relate to the starting bacterial community in 347 
this horse, as all models were treated identically, except for inoculation with feces from 348 
different horses. The ability of this in vitro system to replicate aspects of bacterial 349 
community profile representative of the equine large intestine is consistent at phylum, 350 
class and order level. 351 
Many of the low abundance bacterial taxa identified in the gastrointestinal 352 
content were absent from the gut model. Significant differences were found when 353 
comparing the OTUs identified in the gut models at T5 to the areas in the large 354 
intestine that they represent. These OTUs may correspond to non-viable bacteria that 355 
were detected in the gastrointestinal content and feces of horses, but were not able to 356 
survive and proliferate in the gut model. Alternatively, it may reflect the failure of the 357 
model to provide the exact environmental conditions needed to support the vast 358 
number of low abundance bacterial groups normally found within the horse large 359 
intestine. Clearly, a limitation of this model is that it does not support growth and 360 
function of all the taxonomic diversity present in the large intestine of horses. To allow 361 
a more diverse bacterial community to establish, other features of the equine large 362 
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intestine may need to be added to the model, such as epithelial cells and gut wall 363 
secretions. By visualizing the unique OTUs that are shared between the gut model 364 
vessels and the gastrointestinal content in a Venn diagram, we can see that the gut 365 
models were able to maintain the bacteria that contribute to 39 – 43% of the unique 366 
OTUs identified in the gastrointestinal samples of horses. 367 
Our studies have indicated that the equine gut model may capture some 368 
aspects of inter-individual variation seen in the gut microbiota of equine populations. 369 
Inoculating models with feces from different horse donors resulted in different bacterial 370 
community profiles by the time steady state is reached. This important aspect of the 371 
model is worthy of further exploration as it may allow the investigation of individual 372 
responses to food supplements and susceptibility to diseases that are mediated via 373 
the gut microbiota. 374 
In the repeatability study two identical gut models were inoculated with feces 375 
from the same horse. SCFA/BCFA levels measured by gas chromatography showed 376 
that their production was similar in the two gut models of the repeatability study. 1H 377 
NMR analysis of supernatants from these two models showed that metabolic profiles 378 
of the vessels were similar at all time points after T1. FISH analysis estimating the total 379 
number of bacteria maintained by the two models showed that differences in total 380 
bacteria between the three vessels were similar across the models. Bacterial DNA 381 
sequencing of samples taken from the three vessels of these two models at T5 showed 382 
comparable taxonomic profiles at both phylum and class level. Bacterial community 383 
profiles were stable for the two models between T5 and T7. The repeatability study 384 
provide preliminary evidence that models inoculated with the same fecal matter will 385 
produce microbial communities that are similar, both structurally and functionally. 386 
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We have reported the analyses used to assess the microbial and metabolic 387 
output of a three stage equine gut model. The model is metabolically functional and is 388 
able to support a bacterial community which replicates aspects of that found in the 389 
equine large intestine. This model is not an exact replication of in vivo bacterial 390 
community of the equine large intestine, but does provide an in vitro alternative to 391 
studies that involve invasive or post-mortem sampling of horses. These may be 392 
particularly valuable for studying cecal microbiota, for which feces are not an adequate 393 
proxy. This model has the potential to aid in the understanding of how the equine gut 394 
microbiota is affected by diet, disease and drugs. 395 
 396 
MATERIALS AND METHODS 397 
Equine gastrointestinal content collection. 398 
Samples of gastrointestinal content were obtained from horses, free of gastrointestinal 399 
disease, no more than three hours after euthanasia. The whole gastrointestinal tract 400 
was removed from the carcass and the large intestine identified. From each horse, 401 
two, 12 ml tubes were filled with content from the following areas: cecum, left ventral 402 
colon, right ventral colon and feces from the end of the small colon. Measurement of 403 
pH of fresh gut contents at all sample sites was achieved using a calibrated, hand-404 
held pH monitor. Samples were transported on dry ice, then stored at -80 °C prior to 405 
analysis. Descriptive details of all horses sampled can be found in Table S1.  406 
 407 
Compositional analysis of gastrointestinal content. 408 
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To inform the make-up of media ADF and starch content of gastrointestinal samples 409 
from three UK leisure horses (horse 1, 2 and 3 in Table S1) were analyzed. Samples 410 
were all free-dried to remove all moisture. ADF content of free-dried samples were 411 
analyzed using the filter bag technique (ANKOM technology). Starch content of 412 
samples were analyzed by converting starch into glucose by treatment of the hot water 413 
extract with amyloglucosidase followed by acid hydrolysis (29). Total reducing sugars 414 
were measured colormetrically according to Fuller 1967 (30). 415 
 416 
Three stage continuous culture system. 417 
The human gut model developed by Macfarlane et al. 1998 (8) was adapted with the 418 
aim of replicating the microbiota of the cecum, right ventral colon and left ventral colon 419 
of the equine large intestine (Figure 7). This continuous culture system constituted of 420 
three vessels (V1, V2 and V3) with respective volumes of 300 ml, 400 ml and 200 ml 421 
to provide a scaled down version of their respective regions of the equine 422 
gastrointestinal tract. Temperature (at 38 °C by circulating water bath; Optima) and pH 423 
were automatically controlled (by Broadly James F695 pH probes and Fermac 260 pH 424 
measurement and control module; Electrolab) as described in Macfarlane and Eglyst 425 
(31). V1 and V2 were maintained at pH 6.3 - 6.5 and V3 at pH 6.6 - 6.8 to reflect the 426 
pH of the cecum, right ventral colon and left ventral colon respectively. All vessels and 427 
the media reservoir were stirred by magnetic fleas and maintained under anaerobic 428 
conditions by a continuous flow of anaerobic mix gas (80% N2, 10% CO2 and 10% H2). 429 
A single channel, variable speed peristaltic pump (Electrolab) fed vessel one with 430 
media from the media reservoir at a rate of 900 ml every three days which represented 431 
the scaled flow rate of ingesta through the equine gastrointestinal tract. Media then 432 
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flowed from vessel one to two and vessel two to three through the waste pipe of each 433 
vessel. 434 
The human gut model media from MacFarlane et al. 1998 (8) was altered to 435 
mirror the ADF and fibre content seen in compositional analysis of gastrointestinal 436 
content (Figure S1). To represent the normal diet of a horse the percentage of starch 437 
and fibre were increased and the percentage of protein decreased. The composition 438 
of this media in distilled water was: cellulose (15 g litre-1), yeast extract (5 g litre-1), 439 
NaCl (5 g litre-1), KCl (5 g litre-1), mucin (4 g litre-1), raffinose (3.5 g litre-1), starch (2 g 440 
litre-1), peptone water (1.5 g litre-1), tryptone (1.5 g litre-1), NaHCO3 (1.5 g litre-1), 441 
MgSO4(.7H2O) (1.25 g litre-1), arabinogalactan (1 g litre-1), xylan (0.835 g litre-1), 442 
cysteine.HCl (0.8 g litre-1), KH2PO4 (0.5 g litre-1), K2HPO4 (0.5 g litre-1), bile salts (0.4 443 
g litre-1), CaCl2.6H2O (0.15 g litre-1), hemin (0.05 g litre-1), FeSO4.H2O (0.005 g litre-1), 444 
tween 80 (0.5 ml litre-1) and vitamin K (0.01 ml litre-1). 445 
To inoculate the gut model a sample of feces was collected from the rectum 446 
post-mortem or immediately after defecation for non-invasive sample acquisition and 447 
placed in a sealed jar, with an anaerobic atmosphere generating sachet (Oxoid 448 
AnaeroGen 2.5 L Sachet; Thermo Fisher) for transportation for a maximum of two 449 
hours. A 20 % fecal slurry (1 x PBS) was made in a strainer stomacher bag (Seward), 450 
by homogenizing fecal balls manually within an anaerobic cabinet (Whitley A35 451 
anaerobic workstation). 100 ml, 133 ml and 67 ml of the fecal slurry was decanted and 452 
added respectively to each vessel (samples taken immediately after inoculation were 453 
designated T-1). After the fecal slurry was added the model was allowed to equilibrate 454 
as a batch culture for 24 hours. The media pump was started after 24 hours, 455 
designated T0. The short period of batch culture allowed the fecal bacteria to 456 
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acclimatise to their new environment and reduce the washing-out of bacteria when the 457 
flow of media was started. 458 
A sample of 5 ml was taken through the sample port of each vessel at T-1, T0 459 
and every subsequent full turnover of media through the model (every three days). 460 
Two aliquots of 1 ml were centrifuged at 11,337 g, the supernatant stored at -20 °C 461 
and pellets stored at -80 °C. For preparation of FISH slides, an aliquot of 375 µl from 462 
each sample was added to 1125 µl 4 % paraformaldehyde (PFA) and incubated at 5 463 
°C for four hours. PFA was washed off with 1 x PBS, the pellet re-suspended in 150 464 
µl 1 x PBS and 150 µl ethanol and stored at -20 °C until required. Processing of all 465 
samples was carried out in an anaerobic cabinet (Whitley A35 anaerobic workstation). 466 
 467 
Concordance and repeatability studies. 468 
The concordance study used three gut models (M1, M2 and M3) inoculated with feces 469 
from three different horses to assess the similarity between the gastrointestinal 470 
samples and the stabilised fermentation model of the same horse. Modelling three 471 
different individuals allowed assessment of whether the model could capture the inter-472 
individual variation seen in vivo. Samples of gastrointestinal content were taken post 473 
mortem from the cecum, right ventral colon, left ventral colon and feces from the 474 
rectum of three horses (Horses 4, 5 and 6 in Table S1). These samples were 475 
transported on dry ice and then stored at -80 °C until defrosted for analyses. A further 476 
100 g of feces were taken from of each horse and stored in an anaerobic jar (Oxoid) 477 
with an anaerobic gas generating sachet until it was used to make a 20 % fecal slurry 478 
used to inoculate all vessels. Each gut model was sampled every turnover until steady 479 
state was reached (T5, when SCFA/BCFA production stabilised). 480 
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Subsequent to this, two gut models (M4 and M5) were run at the same time 481 
with feces from the same horse, for the repeatability study. This aimed to assess the 482 
reproducibility of the metabolic and bacterial signatures between different gut models. 483 
Freshly voided feces were collected from a healthy horse (Horse 7 in Table S1) and 484 
transported in a sealed container with an anaerobic gas generating sachet to use for 485 
fecal slurry inoculum. These models were run until turnover seven (T7) to assess 486 
stability of the model after steady state (T5) was reached and samples were taken and 487 
processed as previously described. An overview of the inoculation and sampling of the 488 
concordance and repeatability studies can be seen in Figure 8. 489 
 490 
SCFA/BCFA analysis by Gas Chromatography. 491 
Supernatants from all gut models at all time points underwent gas chromatography to 492 
analyse the levels of acetate, propionate, butyrate, isobutyrate and valerate. These 493 
samples were analysed using an acidification method adapted from Zhao et al. 2006 494 
(32). Samples were filtered through 0.2 mm PVDF filer and acidified to pH 2 using 495 
sulfuric acid. An internal standard of 2-ethyl butyrate was added to at 5 mM in each 496 
sample.  A fused-silica capillary column with a free fatty acid phase (DB-FFAP) was 497 
used; with helium as the carrier gas, flow rate of 14.4 ml/min. The initial oven 498 
temperature was 100 °C, which was held for 2 minutes before being raised to 180 °C 499 
at 8 °C per minute and held for a further 2 minutes, then increased to 200 °C at 20 °C 500 
per minute, and held at 200 °C for 5 minute. A range of standards were used at 501 
concentrations from 0.5mM to 100mM, these contained acetate, propionate, butyrate, 502 
iso-butyrate, valerate and isovalerate. Analysis of peak areas was done using 503 
ChemStation B.03.01 software (Aligent Technologies).  504 
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Human gut models are often run for eight turnovers (24 days) before they are 505 
deemed to reach steady state (assessed by the stabilization of SCFA/BCFA levels) 506 
and a drug or feed intervention added (e.g. Grimaldi et al. 2017). We chose to use 507 
SCFA/BCFA production as a marker for model stability, plateauing of production 508 
indicating achievement of steady state (Fig 1). Accordingly, community profiling 509 
models were run until T5 (15 days after media flow was started) as SCFA/BCFA 510 
production was deemed to be stable at this time point; the repeatability study was run 511 
for a further two turnovers after this point to further assess the stability of the model. 512 
Gut models maintained for longer time-periods (data not reported here) have 513 
confirmed stability of SCFA/BCFA production until T7 (21 days after media flow was 514 
started).  515 
 Kruskal-Wallis tests were performed to assess the stability of the SCFA/BCFA 516 
produced by the vessels of the concordance study gut models from T3 to T5 to assess 517 
if steady state had been reached. Kriskall-Wallis tests were also used to assess the 518 
stability of SCFA/BCFA production in the repeatability study gut models from T3 to T5, 519 
from T5 to T7 and whether there were any differences in SFCA/BCFA production 520 
between the two models created with the same fecal inoculum (repeatability study). 521 
 522 
 1H NMR spectroscopy. 523 
Sample supernatants taken from the model were prepared for 1H NMR analysis by 524 
adding 200 µl of phosphate buffer (pH 7.4; 100 % D2O) containing 1 mM of the internal 525 
standard 3-trimethylsilyl-1-[2,2,3,3-2H4] propionate (TSP) to 400 µl of each sample 526 
and transferred into 5 mm NMR tubes. Spectroscopic analysis of all samples was 527 
carried out on a 700 MHz Bruker NMR spectrometer equipped with a cryo-probe. 528 
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Standard one-dimensional 1H NMR spectra were acquired for all samples with water 529 
peak suppression using a standard pulse sequence. For each sample, 8 dummy scans 530 
were followed by 256 scans and collected in 64K data point. Chemical shifts in the 531 
fecal spectra were referenced to the TSP singlet at δ 0.0. Scans collected 64K data 532 
points. A spectral width of 20 ppm and an acquisition time per scan of 3.12 seconds 533 
were used. 534 
1H NMR spectra were analysed in the Matlab environment (R2014a; 535 
Mathworks) with in-house scripts. Spectra were initially aligned and normalized 536 
(probabilistic quotient method) before multivariate models were built to compare the 537 
metabolic profiles of gastrointestinal content to sample supernatants from the gut 538 
model. Initial unsupervised PCA models were constructed to identify metabolites that 539 
explain the largest sources of variation within the dataset. OPLS-DA models were 540 
constructed for pair-wise comparisons of gastrointestinal content and gut model 541 
supernatants. The predictive ability (Q2Y) of the OPLS-DA models were calculated 542 
using seven-fold cross validation. Metabolites were assigned to peaks using the 543 
database of equine metabolites found in Escalona et al. (33). 544 
 545 
FISH analysis for total bacteria. 546 
FISH was used alongside 16S gene sequencing in order to enumerate bacteria. It 547 
provides a validated approach for counting total microbial numbers using probes 548 
targeting specific bacterial taxa. FISH analyses were carried out by a trained operator; 549 
quality assurance was provided by duplicate counting by second operator which gave 550 
rise to comparable results (greater than 95% confidence of similarity). Total bacterial 551 
count per ml was calculated by utilising Eubmix FISH probe. This is a mixture of three 552 
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EUB338 probes (I, II and III, Sigma Aldrich) with the dye Cy3 tagged at the 5’ end. 553 
Hybridisation was performed as described in Daims et al. 1999 (34). All samples 554 
prepared for FISH were diluted to 1 in 100 (in PBS:SDS) and 20 µl was added to a 555 
well of Teflon- and poly L-lysine-coated 6-well slide (Tekdon Inc.). Slides were dried 556 
on a plate incubator for 15 minutes at 46 - 50 °C, dehydrated in 30 %, 80 % and 96 % 557 
ethanol for 3 minutes each and then dried for 2 minutes. Hybridisation mixture (0.9 M 558 
NaCl, 0.02 M Tris/HCl (pH 8), formamamide, 10 % sodium dodecyl sulphate and 4.55 559 
ng ml-1 probe) was added to each well, slides placed on a sealed tray and put in a 560 
hybridisation oven for 4 hours at 46 °C. Once hybridisation was complete slides were 561 
placed into wash buffer (0.9 M NaCl, 0.02 M Tris/HCl (pH 8) 0.005 M EDTA solution 562 
(pH 8), H2O) for 10 - 15 minutes at 48 °C. After washing slides were dipped into cold 563 
water for 2 - 3 seconds and dried using compressed air. Once dry, antifade solution 564 
(Dabco) was added to each well and a cover slip applied. Fixed bacteria were 565 
visualised using fluorescence microscopy (Nikon Eclipse Ni-U microscope), the 566 
number of bacteria counted in 15 random fields of view per well and a mean calculated. 567 
To calculate the number of bacteria per ml the following equation was used: 568 
𝐵𝑎𝑐𝑡𝑒𝑟𝑖𝑎 𝑝𝑒𝑟 𝑚𝑙 = 0.8 × 𝑚𝑒𝑎𝑛 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎 × 6788.42 × 50 × 100 569 
 570 
Preparation and analysis of bacterial DNA sequencing. 571 
DNA was extracted from frozen gastrointestinal samples and pellets from the gut 572 
model using PSP® spin stool DNA plus kit (Invisorb) using the manufacturer’s 573 
protocol. Extracted DNA was re-suspended in 100 µl of elution buffer. Further 574 
preparation and DNA sequencing was carried out by the Centre of Genomic Research, 575 
Liverpool. The extracted DNA was amplified using PCR of the V4 region of the 16S 576 
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rRNA gene using the primers F515 (GTGCCAGCMGCCGCGGTAA) and 806R 577 
(GGACTACHVGGGTWTCTAAT) (35), with reverse primers containing individual 578 
Golay barcodes.  For a final volume of 20 µl to be subjected to V4 PCR 1 µl of the 579 
extracted DNA from each sample was added to: 7 µl of molecular water, 10 µl 580 
NEBNext High Fidelity Master Mix (New England Biolabs), 1 µl of forward primer (3 581 
µM) and 1 µl of an individually barcoded reverse primer (3 µM). This mixture was made 582 
for each individual sample, which then underwent the following PCR conditions: 30 583 
seconds at 98 °C and 25 cycles of: 10 seconds at 98 °C, 30 seconds at 55 °C and 30 584 
seconds at 72 °C. This was followed by a final period of 5 minutes at 72 °C and then 585 
kept at 4 °C until processed. PCR products were evaluated by electrophoresis in 2 % 586 
agarose gel stained with midori green. Successfully amplified DNA was cleaned using 587 
AMPure XP beads (Agencourt) and quantified using the Quant-iT PicoGreen dsDNA 588 
assay (Life Tech). PCR products were pooled at an equimolar ratio and size selected 589 
using a 2 % agarose gel cassette run in a Pippin Prep (Sage Science machine) where 590 
fragments at 254 bp were eluted and kept for sequencing. Sequencing was carried out 591 
on the MiSeq Illumina platform. 592 
 Analysis of sequencing data was carried out on a remote linux server provided 593 
by the University of Surrey with QIIME2 (36) installed. Zipped read files were uploaded 594 
to the linux server and converted into a QIIME artefact (qiime tools import) and a 595 
summary was generated (qiime demux summarize). Quality control was carried out 596 
using DADA2 (37) and the ends of reads were trimmed at position 15 and 220 of the 597 
reads (qiime dada2 denoise-single). A rooted phylogenetic was generated for diversity 598 
analyses (qiime alignment mafft, qiime alignment mask, qiime phylogeny fasttree and 599 
qiime phylogeny midpoint-root). Diversity core metrics were generated at a sampling 600 
depth of 47,000 reads (qiime diversity core-metrics-phylogenetic) and boxplots 601 
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displaying alpha diversity (measure as observed OTUs) were generated (qiime 602 
diversity alpha-group-significance). The reference database greengenes (38) was 603 
downloaded and the taxanomic classifiers were trained on this specific sample 604 
preparation and sequencing parameters (qiime feature-classifier classify-sklearn). 605 
Taxa summary barplots were generated (qiime taxa barplot). 606 
Mann-Whitney U tests were used to assess whether read numbers for identified 607 
bacterial phyla were statistically different when comparing gastrointestinal content to 608 
the gut model and time points of the model. Venn diagrams were generated to 609 
visualise how many identifiable and uniquely named OTUs were shared between the 610 
vessels of the three biological replicate gut models and their corresponding 611 
gastrointestinal compartments. Regression models were built with the mean 612 
SCFA/BCFA concentration and bacterial phyla count for the each vessel of the 613 
concordance study at T-1, T0 and T5. Correlations identified by the models were 614 
deemed to be significant when R2 = 0.5 and p < 0.05. Venn diagrams were generated 615 
to visualise how many identifiable and uniquely named OTUs were shared between 616 
the vessels of the three biological replicate gut models and their corresponding 617 
gastrointestinal compartments. 618 
Raw sequencing reads analysed in this manuscript have been submitted to the 619 
European Nucleotide Archive and can be found in project ERP107630. 620 
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Figures 765 
Figure 1: Demonstration of biological functionality of the gut models in the 766 
concordance study. SCFA/BCFA production of the three separate gut models 767 
inoculated with feces from three different horses during the concordance study (shown 768 
as the mean and standard deviation of the three vessels of the model). The 769 
SFCA/BCFAs measured were: A) acetate, B) propionate, C) butyrate, D) isobutyrate 770 
and E) valerate. T, turnover; V, vessel. 771 
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Figure 2: Biochemical variation (measured by 1H NMR spectroscopy) between the gut 772 
contents of donor horses and in vitro gut model supernatant from the concordance 773 
study. A) PCA scores plot for PC1 and PC2 of the model (R2 = 0.64). B) The loading 774 
plot for PC1, describing 50 % of the total variance associated with higher concentration 775 
of acetate in model supernatant at time poinrs T1 – T5 and C) the loading plot for PC2 776 
describing 14 % of the total variance, associated with higher acetate concentration in 777 
gut contents. PC, principle component; T, turnover. 778 
 779 
 780 
 781 
 782 
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Figure 3: Relative abundance of the bacterial phyla (assigned by 16S bacterial gene 783 
sequencing) identified in the gastrointestinal content from donor horses and the three 784 
gut models from the concordance study. The key indicates whether bacterial phyla 785 
are: identified in both gastrointestinal and gut model samples at T5 (black), only in 786 
gastrointestinal samples (blue) or only in gut model samples (red). C, cecum; RVC, 787 
right ventral colon; LVC, left ventral colon; V, vessel; T, turnover; M, model.  788 
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Figure 4: Venn diagram showing the total number of distinct OTUs that are unique 789 
and shared between samples taken from the areas of the equine large intestine and 790 
their corresponding vessels from the gut models. These models were from the 791 
concordance study used to capture individual variation. 792 
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Figure 5: Demonstration of repeatability of biological function between models. 793 
SCFA/BCFA production (measured by gas chromatography) in each vessel of the 794 
models was inoculated with the same feces (repeatability study). Each line represents 795 
the level of a SCFA/BCFA in a single vessel of one of the two gut models of the 796 
repeatability study. The SFCA/BCFAs measured were: A) acetate, B) propionate, C) 797 
butyrate, D) isobutyrate and E) valerate. T, turnover; R, technical replicate; V, vessel; 798 
M, model.  799 
Figure 6: Demonstration of the repeatability of model bacterial communities. 800 
Taxonomic assignments (phyla from 16S bacterial gene sequencing) from the 801 
repeatability study; two models inoculated with feces from the same horse. M, model; 802 
V, vessel; T, turnover. 803 
 804 
 805 
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Figure 7: Three stage, in vitro, 806 
fermentation model designed to 807 
replicate the microbiota of the equine 808 
cecum, right ventral colon and left 809 
ventral colon (modified from 810 
MacFarlane et al. 1998). 811 
 812 
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Figure 8: Schematic showing the sampling scheme and experimental design for A) 827 
concordance study to demonstrate capture of inter-individual variation and B) 828 
repeatability study to demonstrate consistency of models inoculated with the same 829 
feces. 830 
